Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-851-5 | CAS number: 100-42-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study (GLP study)
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 004
- Report date:
- 2004
- Reference Type:
- review article or handbook
- Title:
- European risk assessment report, Styrene CAS No. 100-42-5, EINECS No. 202-851-5, Draft for submission to SCHER, November 2007.
- Author:
- European Union
- Year:
- 2 007
- Bibliographic source:
- Styrene CAS No. 100-42-5, EINECS No. 202-851-5, Draft for submission to SCHER, November 2007
Materials and methods
- Objective of study:
- metabolism
- Principles of method if other than guideline:
- In vitro study on the characterisation of reactive metabolites (not measurable in vivo due to the rapid metabolism) of styrene, arising via the initial hydroxylation to 4-Vinylphenol, in the lung and/or liver tissue of mouse, rat and human donors.
- GLP compliance:
- yes
Test material
- Reference substance name:
- Styrene
- EC Number:
- 202-851-5
- EC Name:
- Styrene
- Cas Number:
- 100-42-5
- Molecular formula:
- C8H8
- IUPAC Name:
- ethenylbenzene
Constituent 1
- Specific details on test material used for the study:
- Non-radiolabelled chemicals
- Name of test material (as cited in study report): 4-vinylphenol
- Analytical purity: 100 %
- Lot/batch No.: 10902
- Name of test material (as cited in study report): styrene
- Analytical purity: 99.4 %
- Lot/batch No.: 17129EA
Radiolabelled chemicals:
- Name of test material (as cited in study report): radiolabeled 4VP
- Lot/batch No.: 170-095-004
- Radiochemical purity (if radiolabelling): >98 %
- Specific activity (if radiolabelling): 4 mCi/mmol
- Locations of the label (if radiolabelling): ring-U
- Name of test material (as cited in study report): radiolabeled styrene
- Lot/batch No.: 170-134-004
- Radiochemical purity (if radiolabelling): 100 %
- Specific activity (if radiolabelling): 4 mCi/mmol
- Locations of the label (if radiolabelling): ring-U - Radiolabelling:
- yes
- Remarks:
- 14C-styrene and 14C-4-vinylphenol
Test animals
- Species:
- other: human, mouse, rat
- Strain:
- other: CD1 mice, sprague-dawley rats
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratory (Portage, Michigan, USA)
- Mean age at the time of tissue collection: mice: 13.3 weeks, rats 11.4 weaks
HUMAN TISSUE
Microsomes from liver or lung tissue of human donors (mixed gender) were obtained from Xenotech LLC (Lenexa, Kansas, USA).
Administration / exposure
- Route of administration:
- other: in vitro incubation in 0.1 M phosphate buffer (pH 7.4)
- Vehicle:
- propylene glycol
- Details on exposure:
- Microsomes of liver and lung tissue obtained from male CD1 mice, male SD rats and human donors (50 and 4 donors of mixed genders for liver and lung samples respectively) were incubated with 0.01, 0.1 or 1.0 mM styrene or with 0.05 or 0.5 mM 4-VP. Selected mouse styrene or 4-VP incubations were used to determine the metabolic production of CO2. In addition, selected styrene incubations were analysed for the production of 4-VP and selected 4-VP lung microsomal incubations were performed in the presence of excess glutathione (GSH) in order to trap reactive 4-VP metabolites.
- Duration and frequency of treatment / exposure:
- METABOLITE IDENTIFICATION:
Microsomal incubations were performed for 30 minutes at 37ºC, with 0.5-0.9 mM NADPH added.
DETERMINATION OF METABOLIC CO2 PRODUCTION:
Microsomal incubations with addition of KOH prior to substrate addition
TRAPPING OF REACTIVE METABOLITES
Addition of 5-9 mM GSH prior to substrate addition
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0.01, 0.1 or 1.0 mM styrene
0.05 or 0.5 mM 4-Vinylphenol
- No. of animals per sex per dose / concentration:
- not applicable
- Control animals:
- other: not applicable
- Positive control reference chemical:
- Selected control samples were prepared by omitting either substrate or NADPH cofactor.
- Details on dosing and sampling:
- IN VITRO METABOLITE CHARACTERISATION STUDIES
- Tissues sampled: Lungs and liver of mice and rat; Microsomes from liver or lung tissue of human donors.
- Method type(s) for identification: GC-MS, reversed-phase LC-ESI/MS/MS (Liquid Chrormtography/Mass Spectrometry)
Results and discussion
- Preliminary studies:
- not applicable
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- Recovery of radioactivity from incubations of [14C]-4VP ranged from 83.4 - 95.1 %.
Recovery of radioactivity from incubations of [14C]-styrene ranged from 68.2 - 86.6 % and 86.2 - 97.4 % for liver and lung, respectively. - Details on distribution in tissues:
- not applicable
- Details on excretion:
- not applicable
Metabolite characterisation studies
- Metabolites identified:
- yes
- Details on metabolites:
- Incubations of 4-VP with mouse lung microsomes produced two major and several minor reactive metabolites. By incubating these mouse lung microsomes with 4-VP in the presence of excess GSH, the two major metabolites of 4-VP were isolated. These were identified as the GSH conjugates of the side-chain epoxide and the ring-hydroxylated (4-VP hydroquinone) derivatives of 4-VP. The rate of formation of these two 4-VP downstream products was then determined from incubations of styrene with lung microsomes from mouse, rat and human donors in the presence of excess GSH. Relative formation rates for both 4-VP derivatives were highest in mouse lung microsomes (123.35 and 0.325 pmoles/min/mg of 4-VP epoxide GSH conjugate and 4-VP hydroquinone GSH conjugate respectively). Yields of 4-VP epoxide and 4-VP hydroquinone respectively were 79% (97.2 pmoles/min/mg) and 14% (0.045 pmoles/min/mg) lower in rat lung microsomes compared to mouse lung microsomes. Incubates from human lung microsomes contained only 5% (6.4 pmoles/min/mg) of 4-VP epoxide and 1.5% (0.005 pmoles/min/mg) of 4-VP hydroquinone concentrations measured in mouse lung.
Any other information on results incl. tables
No significant production of CO2 was detected following incubation of styrene or 4-VP with microsomes of mouse liver or lung tissue indicating that the liver or lung are not the primary site of aromatic ring cleavage of styrene in the mouse. Substantial species differences were observed in the rate of styrene metabolism in both liver and lung microsomes, with the mouse having the highest styrene conversion (76-80%) compared to the rat (18-29%) and the human donors (0-26%). Following incubation with styrene, only trace levels of 4-VP were found in lung microsomes of both mice (0-0.015% of substrate) and rats (0-0.019%). No measurable 4-VP was detected in human lung microsome incubations. No detectable 4-VP was found in liver microsomes of either mice, rats or humans. These results suggest that conversion of styrene to 4-VP is a minor route of styrene metabolism in vitro and that the small amount of 4-VP produced is subsequently rapidly metabolised.
In human lung the reactive downstream metabolites of 4 -VP are produced to a lesser extent than in rats and much less than in mice lungs. Some caution needs to be exercised, as these are in vitro studies; however, at present, it is not technically possible to perform this kind of study in vivo due to the extreme reactivity of these downstream metabolites.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.